This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> AnaptysBio (ANAB) upgraded to Buy from Neutral at Guggenheim; tgt $44
> Exxon Mobil (XOM) upgraded to Neutral from Underperform at Exane BNP Paribas; tgt $115
> Komatsu (KMTUY) upgraded to Neutral from Sell at Goldman
> Lennox Int’l (LII) upgraded to Neutral from Underweight at JP Morgan; tgt $226
Downgrades:
> Emerson (EMR) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $96
> Steven Madden (SHOO) downgraded to Neutral from Outperform at Wedbush; tgt lowered to $29
> TuSimple Holdings (TSP) downgraded to Perform from Outperform at Oppenheimer
> TuSimple Holdings (TSP) downgraded to Underweight from Overweight at JP Morgan
> Varonis Systems (VRNS) downgraded to Neutral from Outperform at Wedbush; tgt lowered to $20
Others:
> ACADIA Pharmaceuticals (ACAD) initiated with a Hold at Loop Capital; tgt $17
> atai Life Sciences N.V. (ATAI) initiated with a Buy at Loop Capital; tgt $18
> ATS Automation (ATSAF) assumed with an Outperform at RBC Capital Mkts
> Axsome Therapeutics (AXSM) initiated with a Buy at Loop Capital; tgt $95
> Cerevel Therapeutics (CERE) initiated with a Buy at Loop Capital; tgt $40
> Chemours (CC) initiated with an Underperform at Credit Suisse; tgt $24
> COMPASS Pathways (CMPS) initiated with a Buy at Loop Capital; tgt $34
> Evolent Health (EVH) initiated with a Hold at Truist; tgt $33
> Horizon Pharma (HZNP) initiated with a Neutral at H.C. Wainwright; tgt $74
> Karuna Therapeutics (KRTX) initiated with a Buy at Loop Capital; tgt $288
> Kone Oyj (KNYJY) initiated with a Hold at Deutsche Bank
> Legend Biotech (LEGN) initiated with an Outperform at Cowen
> NorthWestern (NWE) initiated with a Neutral at JP Morgan; tgt $55
> OptimizeRx (OPRX) initiated with a Buy at Stifel; tgt $19
> Rocket Pharmaceuticals (RCKT) initiated with a Buy at BTIG Research; tgt $35
> SAGE Therapeutics (SAGE) initiated with a Hold at Loop Capital; tgt $41
> Schindler (SHLAF) initiated with a Buy at Deutsche Bank
> Sumitomo Mitsui (SMFG) resumed with a Buy at Nomura
> Tronox (TROX) initiated with an Underperform at Credit Suisse; tgt $10
> Under Armour (UAA) resumed with a Neutral at BofA Securities; tgt $8
Research calls posted earlier this morning are available here.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
